COVID-19
Therapy Areas
Cardio-metabolic & Vascular
COVID-19
Health Security
Influenza & RSV
Oncology
Solutions for
Newsroom
About
Login

Accurately predicting the vaccine market

Posted on Nov 9, 2021
Airfinity background image landing page

Today, AstraZeneca's Q3 figures were released stating that its COVID-19 Vaccine revenue reached $1.05bn in revenue.

To Airfinity subscribers this wasn’t a surprise as this was just 1% ($8m) off our official forecasts available through our platform. To put this into context, the analyst consensus predicted a more cautious $739m, which turned out to be $311m (30%) below the final amount. 

The future of the COVID-19 vaccine market has an enormous impact on the involved companies and the industry as a whole. 

We are offering a free 30 minute Q&A with a specialised vaccine analyst. You can request a session via our website: https://www.airfinity.com/covid-book-demo

To view our full 2022 COVID-19 Vaccine Revenue Forecast download for free here.

Document Library

Coverage

Sign up to receive the latest insights, product updates and news from Airfinity.

Copyright © Airfinity Limited 2022.
Privacy Policy